Optimizing Architecture of Brain Shuttle-Antisense Oligonucleotide Conjugates for the Treatment of Neurological Disorders in In Vivo Studies

Time: 11:30 am
day: Conference Day One


  • Aspects and conceptual design considerations of brain shuttle-ASO conjugates
  • Analyzing the translational feasibility of this system to revolutionize potentials for clinical systemic targeting of neurological disorders
  • Potential of peripheral administered CNS-targeting ASOs